Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study
Rheumatology International · 2021-06 · 41 (6) · 1115-1124
DOI: 10.1007/s00296-021-04847-x ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Rheumatology International, online erschienen am 03.04.2021. Verfasst von Stefanie D Wade und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology and Clinical Immunology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology and Clinical Immunology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Division of Rheumatology and Clinical Immunology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA. vkyttari@bidmc.harvard.edu.
Zitieren
APA
Wade, S. D., & Kyttaris, V. C. (2021). Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study. Rheumatology International, 41(6), 1115-1124. https://doi.org/10.1007/s00296-021-04847-x
Vancouver
Wade SD, Kyttaris VC. Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study. Rheumatology International. 2021;41(6):1115-1124. doi:10.1007/s00296-021-04847-x
BibTeX
@article{Wade2021,
author = {Wade, Stefanie D and Kyttaris, Vasileios C},
title = {Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study},
journal = {Rheumatology International},
year = {2021},
volume = {41},
number = {6},
pages = {1115--1124},
doi = {10.1007/s00296-021-04847-x}
}
EUVIMED